HomeCompareCNVVY vs GBDC

CNVVY vs GBDC: Dividend Comparison 2026

CNVVY yields 2.51% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CNVVY wins by $156.06M in total portfolio value· pulled ahead in Year 8
10 years
CNVVY
CNVVY
● Live price
2.51%
Share price
$11.56
Annual div
$0.29
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.83M
Annual income
$164,256,279.23
Full CNVVY calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — CNVVY vs GBDC

📍 CNVVY pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNVVYGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNVVY + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNVVY pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNVVY
Annual income on $10K today (after 15% tax)
$213.24/yr
After 10yr DRIP, annual income (after tax)
$139,617,837.35/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, CNVVY beats the other by $125,686,963.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNVVY + GBDC for your $10,000?

CNVVY: 50%GBDC: 50%
100% GBDC50/50100% CNVVY
Portfolio after 10yr
$98.81M
Annual income
$90,322,771.32/yr
Blended yield
91.42%
📊

Analyst Conviction Gap

Where Wall Street is split right now

CNVVY
Analyst Ratings
6
Buy
Consensus: Buy
Altman Z
4.0
Piotroski
7/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNVVY buys
0
GBDC buys
0
No recent congressional trades found for CNVVY or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNVVYGBDC
Forward yield2.51%11.85%
Annual dividend / share$0.29$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%51.1%
Portfolio after 10y$176.83M$20.78M
Annual income after 10y$164,256,279.23$16,389,263.41
Total dividends collected$175.87M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: CNVVY vs GBDC ($10,000, DRIP)

YearCNVVY PortfolioCNVVY Income/yrGBDC PortfolioGBDC Income/yrGap
1$11,202$501.73$12,490$1,790.28$1.3KGBDC
2$13,036$1,050.51$16,522$3,157.73$3.5KGBDC
3$16,234$2,285.17$23,578$5,898.68$7.3KGBDC
4$22,690$5,319.08$37,115$11,886.75$14.4KGBDC
5$38,174$13,895.72$66,136$26,423.57$28.0KGBDC
6$84,544$43,698.21$137,257$66,491.44$52.7KGBDC
7$271,358$180,896.29$341,734$194,868.54$70.4KGBDC
8← crossover$1,375,621$1,085,267.30$1,050,788$685,133.02+$324.8KCNVVY
9$11,755,358$10,283,443.92$4,099,314$2,974,971.01+$7.66MCNVVY
10$176,834,512$164,256,279.23$20,775,530$16,389,263.41+$156.06MCNVVY

CNVVY vs GBDC: Complete Analysis 2026

CNVVYStock

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Full CNVVY Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CNVVY vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNVVY vs SCHDCNVVY vs JEPICNVVY vs OCNVVY vs KOCNVVY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.